PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 69.50
+0.10 (0.14%)
Jan 22, 2026, 10:39 AM CST
PharmaEngine Revenue
PharmaEngine had revenue of 242.16M TWD in the quarter ending September 30, 2025, with 10.97% growth. This brings the company's revenue in the last twelve months to 2.51B, up 201.11% year-over-year. In the year 2024, PharmaEngine had annual revenue of 2.52B with 228.70% growth.
Revenue (ttm)
2.51B
Revenue Growth
+201.11%
P/S Ratio
3.98
Revenue / Employee
56.93M
Employees
44
Market Cap
9.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.52B | 1.76B | 228.70% |
| Dec 31, 2023 | 767.67M | 113.29M | 17.31% |
| Dec 31, 2022 | 654.38M | -452.00K | -0.07% |
| Dec 31, 2021 | 654.84M | -401.18M | -37.99% |
| Dec 31, 2020 | 1.06B | 741.97M | 236.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Adimmune | 1.20B |
| Ever Supreme Bio Technology | 1.01B |
| TCM Biotech International | 682.40M |
| Mycenax Biotech | 649.64M |
| Medigen Vaccine Biologics | 594.96M |
| Tanvex BioPharma | 224.83M |
| OBI Pharma | 49.29M |
| TaiGen Biopharmaceuticals Holdings | 38.75M |